1
0
0
News
neues deutschland vom (neues-deutschland.de)
www.neues-deutschland.de
... seit einigen Wochen auch in Deutschland auf dem Markt. Es wurde von der US-Firma Berlex, einem Tochterunternehmen der Schering AG, entwickelt und dort seit bereits in Fällen bei der Behandlung von MS eingesetzt. Damit sei - so sagte Dr. Claus-Steffen Stürzebecher von der Schering .
Immunotherapy of multiple sclerosis: Where are we? Where should we ...
www.mult-sclerosis.org
Roland Martin1, Claus-Steffen Stürzebecher (2) & Henry F. McFarland (1). (1) Neuroimmunology Branch, NINDS, National Institutes of Health, Building 10, Room 5B-16, 10 Center DR MSC 1400, Bethesda, MD , USA. (2) Clinical Development CNS, Schering AG, Berlin , Germany.
Netzwerk-Profile
LinkedIn: Dr. Steffen Stürzebecher - Chief Medical Officer | LinkedIn
Sehen Sie sich das Profil von Dr. Steffen Stürzebecher auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. Dr. Steffen Stürzebecher hat 12 Jobs im Profil angegeben. Sehen Sie sich auf LinkedIn das vollständige Profil an und erfahren Sie mehr über die Kontakte von Dr. Steffen Stürzebecher und über Jobs bei ...
LinkedIn: Dr. Steffen Stürzebecher | LinkedIn
View Dr. Steffen Stürzebecher's profile on LinkedIn, the world's largest professional community. Dr. Steffen has 11 jobs listed on their profile. See the complete profile on LinkedIn and discover Dr. Steffen's connections and jobs at similar companies.
Steffen Stuerzebecher - Google+
plus.google.com
Report an issue. Help. ©2017 Google • Privacy Policy • Terms of Service • Maps Terms. Region. Search. Sign in. About... Sign in. Profile cover photo. Profile photo. Steffen Stuerzebecher. 5 followers. 5 followers. About. Posts. Looks like you've reached the end. Looks like you've reached the end. Unable to load more.
Interessen
Gaile Renegar, Christopher J. Webster, Steffen Stuerzebecher, Lea ...
philpapers.org
A Framework for Analyzing the Ethics of Disclosing Genetic Research Findings.Lisa Eckstein, Jeremy R. Garrett & Benjamin E. Berkman Journal of Law, Medicine and Ethics 42 (2): Understanding Incidental Findings in the Context of Genetics and Genomics.Mildred K. Cho Journal of Law, Medicine ...
MOR103, a human monoclonal antibody to granulocyte–macrophage ...
ard.bmj.com
We also thank Samson Fung (Fung Consulting, Eching, Germany) and Dominika Weinelt (MorphoSys AG, Martinsried/Planegg, Germany) for contributing to data analysis and interpretation, Steffen Stürzebecher (MorphoSys AG, Martinsried/Planegg, Germany) for reviewing the manuscript, and Sharon L ...
Management & Beteiligungen
Steffen Stürzebecher Berlin - früher Prokurist bei Grünenthal GmbH ...
www.moneyhouse.de
Bei Moneyhouse gibt es ein Manager-Profil zu Steffen Stürzebecher: früher Prokurist bei Grünenthal GmbH.
Business-Profile
Xing: Dr. Steffen Stürzebecher - Senior Vice President, Head of Innovation ...
Berufserfahrung, Kontaktdaten, Portfolio und weitere Infos: Erfahren Sie mehr – oder kontaktieren Sie Dr. Steffen Stürzebecher direkt bei XING.
Steffen Stuerzebecher | M.D., Ph.D. | Grünenthal GmbH, Aachen ...
www.researchgate.net
Steffen Stuerzebecher of Grünenthal GmbH, Aachen with expertise in Neurology, Cell Biology, Neuroscience. Read 49 publications, and contact Steffen Stuerzebecher on ResearchGate, the professional network for scientists.
Dokumente zum Namen
R. Hiatt Karl-Heinz Labs, John A. Dormandy, Kurt A CiteSeerX
citeseerx.ist.psu.edu
Claus-Steffen Stuerzebecher, MD; William R. Hiatt, MD; on Behalf of the Basel PAD Clinical Trial Methodology Group. Abstract—Guidelines for the clinical development of drugs in peripheral arterial disease (PAD) have been issued by the. Food and Drug Administration for the United States and by the regulatory agency of ...
returning genetic research results to individuals - Wiley Online Library
onlinelibrary.wiley.com
GAILE RENEGAR, CHRISTOPHER J. WEBSTER, STEFFEN STUERZEBECHER,. LEA HARTY, SUSAN E. IDE, BETH BALKITE, TARYN A. ROGALSKI-SALTER,. NADINE COHEN, BRIAN B. SPEAR, DIANE M. BARNES AND CELIA BRAZELL1. ABSTRACT. This paper is intended to stimulate debate amongst stakeholders.
MOR103, a human monoclonal antibody to granulocyte OPUS 4
opus4.kobv.de
We also thank Samson Fung (Fung Consulting, Eching,. Germany) and Dominika Weinelt (MorphoSys AG, Martinsried/Planegg, Germany) for contributing to data analysis and interpretation, Steffen Stürzebecher (MorphoSys. AG, Martinsried/Planegg, Germany) for reviewing the manuscript, and Sharon L.
Pharma - eSECURITY Technologies Rolf Oppliger
pubs.esecurity.ch
Claus-Steffen Stürzebecher /. Joachim Reischl / Markus Schröder Seite 24. Complying with Data Privacy Requirements by Joan Antokol. Seite 30. Ubiquitäre Netze und Rechner eröffnen in- teressante Perspektiven. Gleichzeitig ent- stehen aber auch Sicherheitsrisiken. Se- curity und Privacy müssen integrale und.
Wissenschaftliche Veröffentlichungen
Peripheral Arterial Occlusive Disease - ScienceDirect.com
www.sciencedirect.com
How-Steffen Stuerzebecher, Berlin, Germany. Fifty-two ex- ever, for patients who are not eligible for vascularperts from the U.S.A. and Europe, including rep- reconstruction and patients with a critical-risk profile,resentatives from Regulatory Authorities, participated. pharmacological-treatment options may be important.
Veröffentlichungen allgemein
la fundacin para la investigacin en salud concede los - FUINSA
www.fuinsa.org
Dr. Steffen Stürzebecher, Director de Investigación de Grünenthal; Dr. Manuel J. Rodríguez, Jefe de la Unidad del. Dolor del Hospital Regional Universitario “Carlos Haya” de Málaga y Presidente Saliente Sociedad Española del. Dolor (SED); Dr. Emilio Vargas, Subdirector General de Medicamentos de ...
Video & Audio
Steffen Stürzebecher - YouTube
www.youtube.com
Skip navigation. Sign in. Search. Home · Trending · History · Get YouTube Red · Get YouTube TV. Best of YouTube. Music · Sports · Gaming · Movies · TV Shows · News · Live · Spotlight · 360° Video · Browse channels. Sign in now to see your channels and recommendations! Sign in. Info. Shopping. Tap to unmute.
Sonstiges
Brevet WO A oxo-9-fluor-prostaglandin-derivate ...
www.google.dj
Inventeurs, Ulrich Klar, Helmut VORBRÜGGEN, Claus-Steffen Stürzebecher, Karl-Heinz Thierauch. Déposant, Schering Aktiengesellschaft Berlin Und Bergkamen. Exporter la citation, BiBTeX, EndNote, RefMan. Citations de brevets (2), Citations hors brevets (1), Référencé par (1), Classifications (3), Événements juridiques ...
Patent DE A1 - Neue carbacycline, verfahren zu ihrer ...
www.google.com.tj
Publication number, DE A1, DE A1, DE-A , DE , DE A1, DE A1, DE Inventors, Werner Dr Skuballa, Bernd Dr Raduechel, Helmut Prof Vorbrueggen, Claus-Steffen Stuerzebecher, Martin Dr Haberey, Ekkehard Dr Schillinger, ...
Patent EP B1 - Cyclodextrinclathrates of carbacycline ...
www.google.gg
... PCT/DE , PCT/DE , PCT/DE , PCT/DE , PCT/DE , PCT/DE , PCT/DE , PCT/DE Inventors, Werner Skuballa, Helmut VORBRÜGGEN, Helmut Dahl, Claus-Steffen Stürzebecher, Karl-Heinz Thierauch. Applicant, Schering Aktiengesellschaft.
The Feasibility of Personalized Medicine Steffen Stürzebecher, M.D. ...
slideplayer.com
Global Pharmacogenomics, Schering AG ACCP and AGAH joint meeting page AGHA_February.
Claus-Steffen Stürzebecher Berlin
www.telefonbuch10.com
Claus-Steffen Stürzebecher ist in Berlin ist der telefonnumret.
Patent WO A1 - Cyclodextrinclathrates of carbacycline ...
www.google.com
Inventors, Werner Skuballa, Helmut VORBRÜGGEN, Helmut Dahl, Claus-Steffen Stürzebecher, Karl-Heinz Thierauch. Applicant, Schering Aktiengesellschaft. Export Citation, BiBTeX, EndNote, RefMan. Patent Citations (4), Non-Patent Citations (1), Referenced by (8), Classifications (25), Legal Events (10).
Find Steffen Stürzebecher's Email Address & Phone Number | Steffen ...
rocketreach.co
Steffen Stürzebecher's Email Address - | Show email & phone >>>
Ewell Avenue, Kensington - neighbor complaints against ...
neighbor.report
... Gully, Pete Koutromanos, and Anne Loppatto in the US than you thought! SG Solomon J Gully (301) · PK Pete G Koutromanos Age 43 (240) · FL Fulton F Loppato (301) · AL Anne T Loppatto (301) · FL Fulton F Loppatto (301) · SS Steffen Stuerzebecher (301)
Best Practices Project Summaries - Bio-IT World
www.bio-itworld.com
Project Leader: Juergen Heubach & Claus Steffen Stuerzebecher, Bayer Schering Pharma The Project: GENOMatch: genetic custody and privacy. Erasmus MC-University Key Tech Partner: Integromics; Applied Biosystems Project Leader: Leendert H.J. Looijenga, professor in Translational Patho-Oncology ...
Conference Agenda - PRIM&R
www.primr.org
Didactic Sessions and Workshop Series C. (See attached Grid F.) 3:30 – 4:30 PM 8. Concurrent. Panel VIII – Implications of Mixed Missions in Industry-Sponsored Research. (Biomedical). Moderator: Ronald Newbower. Speakers: Barbara Handelin, David Parkinson, Steffen Stürzebecher. November 13, Page
D day invasion research paper. pvma.com.ph
pvma.com.ph
Lothar Weissbach, Steffen Stuerzebecher, Eberhard Mumperow, Theodor Klotz, Dietrich Schnell. Distarch phosphate engineer homework help a resistant starch type 4 RS4 containing phosphodiester cross-links within and between starch molecules. International Relations and the Hungarian Revolution: ...
DBLP: Norbert Luttenberger
vldbarc.org
Norbert Luttenberger, Regine Kollek, Joachim Reischl, Claus-Steffen Stürzebecher: Design of Individual Donor Feedback Processes in Biobank Research. GI Jahrestagung (1) 2006: , Electronic Edition · pubzone.org · CiteSeerX · Google scholar · BibTeX · bibliographical record in XML · Jan Blumenthal, Dirk ...
Effective use of enzyme microreactors - Wageningen UR E-depot - WUR
edepot.wur.nl
system has many reported benefits, such as reduced enviromental, financial, and safety burdens when compared to Stroock, James F. Christian, Arieh M. Karger, and George M. Whitesides An integrated Renegar, Gaile, Christopher J. Webster, Steffen Stuerzebecher, Lea Harty, Su- san E. Ide, Beth Balkite, ...
Forschung für das Leben
www.bio-pro.de
Dr. Annette Fusenig. Head of Corporate Communications. Dr. Steffen Stürzebecher. Global Head of Development. www.grunenthal.de. Janssen-Cilag GmbH.
Frequency of blood CX3CR1-positive natural The FASEB Journal
www.fasebj.org
Susan Pikol,* Isabell Hamann,* Judith Bellmann-Strobl,* Orhan Aktas,* Jan Dörr,*. Jens Wuerfel,* Claus-Steffen Stürzebecher,. ‡ and Frauke Zipp*. *Institute of Neuroimmunology, Neuroscience Research Center, Charité University Hospital. Berlin, Germany;. †. Departments of Genomics & Bioinformatics; ...
Grünenthal GmbH, Aachen - North Data
www.northdata.de
Prokura: Stefan Bluemmers · Nicht mehr Prokura: Steffen Stürzebecher · Aufsichtsratsliste · Gesellschaftsvertrag · Prokura: Rechtsgeschäfte Befugnis · Gesellschaftsvertrag · Jahresabschluss zum Geschäftsjahr vom bis zum
HAROW: the first comprehensive prospective observational study ...
trove.nla.gov.au
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/ s Byline: Lothar Weissbach (1), Steffen Stuerzebecher (1), Eberhard Mumperow (2), Theodor Klotz (3), Dietrich Schnell (1) Keywords: Localized prostate ...
Increased expression of Wnt5a in psoriatic plaques. - Semantic Scholar
www.semanticscholar.org
@article{Reischl2007IncreasedEO, title={Increased expression of Wnt5a in psoriatic plaques.}, author={Joachim Reischl and Susanne Schwenke and Johanna M. Beekman and Ulrich Mrowietz and Steffen Stuerzebecher and J{\"{u}rgen F. Heubach}, journal={The Journal of investigative dermatology}, year={2007}, ...
La terapia combinada, futuro tratamiento de la EM | CuidatePlus
www.cuidateplus.com
Para Steffen Stürzebecher, jefe de la Unidad de Farmacogenómica de Schering AG, laboratorio que comercializa el interferón beta 1b, “el futuro en el tratamiento de la esclerosis múltiple (EM) pasa por investigar en profundidad los mecanismos de acción del interferón, para conseguir mejores resultados.
Randomized phase 1b trial of MOR103, a human antibody to GM-CSF ...
nn.neurology.org
The authors also thank Dr. Steffen Stürzebecher and Dr. Stefan Härtle (MorphoSys AG, Martinsried/Planegg, Germany) for contributing to data analysis, interpretation, and manuscript review, and Susan Spruill, PhD (Applied Statistics and Consulting, Spruce Pine, NC) for critically reading the manuscript.
sortiert nach Relevanz / Datum